This inventor holds 2 USPTO granted patents. Top assignees: The United States of America as Represented by the Department of Health, The Trustees of Boston College. Active years: 1996.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Rothenburg, DE (1996)
- Wurzburg, DE (1996)
Company Filing History:


Years Active: 1996
Title: The Innovative Contributions of Roland G Otz
Introduction
Roland G Otz is a notable inventor based in Rothenburg, Germany. He has made significant contributions to the field of chemistry, particularly in the development of novel alkaloid compounds. With a total of 2 patents, his work has implications for medical applications, including antiviral and antiparasitic treatments.
Latest Patents
Otz's latest patents include innovative methods for synthesizing dimeric arylisoquinoline alkaloid compounds. This invention provides a method of preparing these compounds by coupling two isoquinoline building blocks with a biaryl building block. The result is the formation of homodimers or heterodimers, which includes the antiviral michellamines. Additionally, he has developed methods for preparing monomeric naphthylisoquinoline alkaloids, which encompass antiparasitic korupensamines and related compounds. This invention also introduces new, medically useful naphthylisoquinoline compounds and derivatives.
Career Highlights
Throughout his career, Otz has worked with esteemed organizations, including the United States of America as represented by the Department of Health and the Trustees of Boston College. His work has been instrumental in advancing the understanding and application of alkaloid compounds in medicine.
Collaborations
Otz has collaborated with notable colleagues such as Gerhard Bringmann and Michael R Boyd. These partnerships have contributed to the success and impact of his research in the field.
Conclusion
Roland G Otz's innovative work in the synthesis of alkaloid compounds showcases his dedication to advancing medical science. His patents reflect a commitment to developing new treatments that can benefit society.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile